2.The Hayflick limit, as the upper bound is known (after Leonard Hayflick, the biologist who discovered it), is believed to be an anticancer mechanism.
4.The simultaneous and efficient delivery of cisplatin and pooled siRNAs to ovarian cancer can allow for enhanced anticancer efficacy by blocking drug resistance pathways.
5.At a time when it is hard to raise new capital, the firm has decided to concentrate on anticancer therapies that, it hopes, are nearer to being commercial propositions than the stem-cell study is.